Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon

[1]  M. Boussinesq,et al.  Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon , 2020, BMC Public Health.

[2]  M. Boussinesq,et al.  A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy , 2020, Open forum infectious diseases.

[3]  R. Colebunders,et al.  Nodding syndrome research, lessons learned from the NSETHIO project , 2019, Global Mental Health.

[4]  M. Boussinesq,et al.  The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study. , 2018, The Lancet. Infectious diseases.

[5]  G. Quattrocchi,et al.  Updated evidence of the association between toxocariasis and epilepsy: Systematic review and meta-analysis , 2018, PLoS neglected tropical diseases.

[6]  J. Kamgno,et al.  Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon , 2018, Parasites & Vectors.

[7]  M. Begon,et al.  High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo , 2017, PLoS neglected tropical diseases.

[8]  P. Preux,et al.  Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy , 2017, PLoS neglected tropical diseases.

[9]  M. Boussinesq,et al.  Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment , 2016, Parasites & Vectors.

[10]  D. Stadler,et al.  Environmental, dietary and case-control study of Nodding Syndrome in Uganda: A post-measles brain disorder triggered by malnutrition? , 2016, Journal of the Neurological Sciences.

[11]  M. Begon,et al.  Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case–control study , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[12]  R. Post,et al.  Nodding syndrome--we can now prevent it. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  G. Eslick,et al.  Cerebral malaria as a risk factor for the development of epilepsy and other long-term neurological conditions: a meta-analysis. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  D. Bhalla,et al.  Toxoplasmosis and Epilepsy — Systematic Review and Meta Analysis , 2015, PLoS neglected tropical diseases.

[15]  Pierre-Marie Preux,et al.  Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa , 2014, The Lancet Neurology.

[16]  B. Lowe,et al.  Exposure to Multiple Parasites Is Associated with the Prevalence of Active Convulsive Epilepsy in Sub-Saharan Africa , 2014, PLoS neglected tropical diseases.

[17]  J. Engel,et al.  ILAE Official Report: A practical clinical definition of epilepsy , 2014, Epilepsia.

[18]  M. Boussinesq,et al.  Case-control Studies on the Relationship between Onchocerciasis and Epilepsy: Systematic Review and Meta-analysis , 2013, PLoS neglected tropical diseases.

[19]  Josemir W Sander,et al.  Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies , 2013, The Lancet Neurology.

[20]  H. García,et al.  Epilepsy in poor regions of the world , 2012, The Lancet.

[21]  G. Quattrocchi,et al.  Toxocariasis and Epilepsy: Systematic Review and Meta-Analysis , 2012, PLoS neglected tropical diseases.

[22]  I Kleinschmidt,et al.  Incidence of epilepsy , 2011, Neurology.

[23]  A. Winkler,et al.  The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania , 2010, Parasitology.

[24]  Christian Bottomley,et al.  Estimation of the burden of active and life-time epilepsy: A meta-analytic approach , 2010, Epilepsia.

[25]  P. Jallon,et al.  A survey of public knowledge, attitudes, and practices with respect to epilepsy in Badissa Village, Centre Region of Cameroon , 2009, Epilepsy & Behavior.

[26]  P. Preux,et al.  Epilepsy in Onchocerciasis Endemic Areas: Systematic Review and Meta-analysis of Population-Based Surveys , 2009, PLoS neglected tropical diseases.

[27]  M. Rinaldis,et al.  High prevalence of epilepsy in a village in the Littoral Province of Cameroon , 2008, Epilepsy Research.

[28]  C. I. Chikwendu,et al.  Onchocerciasis and epilepsy in parts of the Imo river basin, Nigeria: a preliminary report. , 2006, Public health.

[29]  P. Preux,et al.  [Dépistage de l'épilepsie en zones tropicales: validation d'un questionnaire en Mauritanie]. , 2006, Bulletin de la Societe de pathologie exotique.

[30]  M. Druet‐Cabanac,et al.  [Cysticercosis and epilepsy: a case-control study in Mbam Valley, Cameroon]. , 2004, Bulletin de la Societe de pathologie exotique.

[31]  M. Druet‐Cabanac,et al.  Review of Epidemiological Studies Searching for a Relationship between Onchocerciasis and Epilepsy , 2004, Neuroepidemiology.

[32]  M. Boussinesq,et al.  Demographic Impact of Epilepsy in Africa: Results of a 10‐year Cohort Study in a Rural Area of Cameroon , 2003, Epilepsia.

[33]  C. Mandlhate,et al.  The global campaign against epilepsy in Africa. , 2003, Acta tropica.

[34]  M. Boussinesq,et al.  Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  Preux Pm.  Questionnaire in a study of epilepsy in tropical countries , 2000 .

[36]  M. Boussinesq,et al.  Les déterminants géographiques de la transmission de l’onchocercose en zone de transition forêt-savane : l’exemple de deux villages du foyer du Mbam (région du Centre, Cameroun) , 1999 .

[37]  P. Barbazan,et al.  [Geographic determinants of onchocerciasis transmission in a forest-savannah transition zone: an example of 2 villages of the Mbam focus (central region, Cameroon)]. , 1998, Sante.

[38]  J. Bradley,et al.  Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[39]  M. Boussinesq,et al.  Etude épidémiologique d'une distomatose à Paragonimus sp. au sud-Cameroun , 1995 .

[40]  W. Kipp,et al.  Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in rural western Uganda. , 1992, East African medical journal.

[41]  G. Burnham,et al.  Improvement in seizures after ivermectin , 1992, The Lancet.

[42]  B. Osuntokun,et al.  Prevalence of the Epilepsies in Nigerian Africans: A Community‐Based Study , 1987, Epilepsia.

[43]  Osuntokun Bo.  Epilepsy in Africa. Epidemiology of epilepsy in developing countries in Africa. , 1978 .

[44]  B. Duke,et al.  Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. , 1976, Tropenmedizin und Parasitologie.

[45]  P. Preux.  [Questionnaire in a study of epilepsy in tropical countries]. , 2000, Bulletin de la Societe de pathologie exotique.

[46]  M. Leichsenring,et al.  The prevalence of epilepsy follows the distribution of onchocerciasis in a west Ugandan focus. , 1996, Bulletin of the World Health Organization.

[47]  M. Boussinesq,et al.  [Epidemiological study of Paragonimus sp. in south Cameroon]. , 1995, Bulletin de la Societe de pathologie exotique.

[48]  J. Remmé.  Epidemiology and control of onchocerciasis in West Africa. , 1989, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.